Lifestyle & Wellness
-

Kokilaben Dhirubhai Ambani Hospital earns prestigious spot in Newsweek’s World’s best Hospitals for Seventh Consecutive Year
~ A Prestigious Global Honor Strengthening Clinical Excellence & Patient-Centric Innovation ~ Mumbai : In a remarkable feat of consistency and medical leadership, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai, has once again…
-

Adesh Kumar Tyagi on Tryfacta’s Strategic Expansion into Defense Healthcare
National : Tryfacta Inc is steadily making its mark in the U.S. federal healthcare sector, with recent contracts highlighting its growing influence in military medical services. The company has secured over $62 million in task…
-

Snapdeal Expands Summer Fashion: Trendy Styles at Value Prices
Mumbai : Value e-commerce marketplace, Snapdeal, has expanded its fashion portfolio for the summer season with the onboarding of a new set of popular new-age brands and labels across men’s and women’s categories. The platform’s…
-

Alkem Brings Affordable Semaglutide to India: Weekly Therapy at ₹450
Mumbai : Alkem Laboratories Ltd. (BSE: 539523, NSE: ALKEM, “Alkem” and its subsidiaries) today announced the launch of semaglutide injection in India under the brand names “Semasize”, Obesema” and “Hepaglide”. Semaglutide is administered as a…
-

Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India
Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325 Bangalore, India : Glenmark Pharmaceuticals Ltd (Glenmark), a research-led, global pharmaceutical company, today announced the launch of GLIPIQⓇ (semaglutide) in…
-

Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
Bangalore : Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as “Zydus”), an innovation-led global lifesciences company, has launched Semaglutide Injection under the brand names – SEMAGLYNTM, MASHEMATM and ALTERMETM, upon patent expiry in…





